Results 261 to 270 of about 5,857,342 (337)

Emergency PCI and TAVR for Acute Myocardial Infarction in Severe Aortic Stenosis Patients

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Transcatheter aortic valve replacement (TAVR) is a viable alternative for patients with symptomatic severe aortic stenosis. Acute myocardial infarction is a contraindication to TAVR. The efficacy of emergency TAVR combined with percutaneous coronary intervention for patients presenting with acute myocardial infarction, severe aortic stenosis ...
Ruiyuan Lin, Zheng Li, Zhen‐wei Liang, Yuan‐ Yao, Xian‐zi Zeng, Xiao‐mei Gao, Heng‐ Zhang, Zhuo‐Ya Li, Kun Wang, Xiao‐fei Jiang   +9 more
wiley   +1 more source

Optimizing Primary PCI Care for STEMI Patients: Key Messages From the SCAI Expert Consensus Statement. [PDF]

J Soc Cardiovasc Angiogr Interv
d'Entremont MA, Jolly SS.
europepmc   +1 more source

Prescriptions for Excellence in Health Care Spring 2010 Dowload Full PDF [PDF]

, 2010

core   +1 more source

Hand Dysfunction After Intervention via Distal Versus Conventional Transradial Access: A Meta‐Analysis of Randomized Trials

Clinical Cardiology, Volume 49, Issue 5, May 2026.
This meta‐analysis of randomized controlled trials found that, compared with the conventional transradial access (TRA), the distal transradial access (dTRA) may reduce hand clumsiness and persistent pain, but it increases hand numbness. ABSTRACT Background Percutaneous coronary intervention (PCI) is an important treatment for coronary artery disease ...
Xinyu Fan, Tong Zhou, Feng Li, Ganwei Shi, Chenlei Gu, Ziyang Chen, Gaojun Cai   +6 more
wiley   +1 more source

Evaluation of the Relationship between QT Dispersion in ECG and Response to Primary PCI in Patients with Acute Myocardial Infarction. [PDF]

Med J Islam Repub Iran
Ghods Hosseini MMS, Dodangeh S, Javadi HR, Razaghi A, Haji Karimi M.   +4 more
europepmc   +1 more source

The Effect of Empagliflozin on Renal Outcomes in Patients With Established Cardiovascular Disease: Systematic Review and Meta‐Analysis of Randomised Placebo‐Controlled Trials

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Empagliflozin may be significantly reducing the risk of CKD outcome in patients with CVD compared with placebo. Empagliflozin also had a favourable safety profile. ABSTRACT Background Empagliflozin, a sodium‐glucose cotransporter‐2 inhibitor (SGLT2i), may be associated with improved renal outcomes.
Mansour Bahardoust, Fatemeh Naseri Rad, Sepideh Mousavi, Mohammadsadra Shamohammadi, Meisam Haghmoradi, Azin Ghaffari   +5 more
wiley   +1 more source

TEN-YEAR OUTCOMES AFTER ACUTE STEMI TREATED WITH PRIMARY PCI - THE ROLE OF ACUTE BIOMARKERS AND OTHER PARAMETERS IN PREDICTING CLINICAL SEVERITY AND PROGNOSIS. [PDF]

Acta Clin Croat
Mornar Jelavić M, Babić Z, Babić D, Balenović D, Lipovšćak R, Pintarić H.   +5 more
europepmc   +1 more source

Investigating Novel Inflammatory Indices and Their Links to Mortality, Cancer, and Cardiovascular Disease: A 10‐Year Cohort Study

Health Science Reports, Volume 9, Issue 5, May 2026.
Abstract Background and Aims Inflammatory indices, including neutrophil‐to‐lymphocyte‐platelet ratio (NLPR), systemic immune‐inflammation index (SII), platelet‐to‐lymphocyte ratio (PLR), and neutrophil‐to‐lymphocyte ratio (NLR) have been proposed as prognostic markers for mortality.
Mahboobeh Ghasemzadeh Rahbardar, Homina Saffar, Niloofar Shabani, Habibollah Esmaily, Moein Najib, Mana Moghadasian, Seyedeh Atiyeh Mousavifard, Mohsen Moohebati, Sara Saffar Soflaei, Majid Ghayour‐Mobarhan   +9 more
wiley   +1 more source

Correlation between admission blood glucose, fibrinogen, and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction. [PDF]

Front Cardiovasc Med
Zufei W, Wentao S, Chen S, Xu BD, Zong GJ, Wu GY.   +5 more
europepmc   +1 more source